P8A:SGX
Cordlife Group Ltd
SGD 0,12
0,00%
(0,00) 1G
12 Eki, 09:49:20 GMT+8 · SGD
search
Tüm semboller
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoP8A ile ilgili en önemli analizler oluşturuluyor...
Piy. değ.
32,37 Mn
Ort. hacim
1,32 B
İşlem Hacmi
0,00
52 haftalık en yüksek
SGD 0,26
52 haftalık en düşük
SGD 0,10
HBK
-SGD 0,04
Tedavüldeki hisse senedi sayısı
267,53 Mn
Çalışan sayısı
111
Piy. değ.
32,37 Mn
Ort. hacim
1,32 B
İşlem Hacmi
0,00
52 haftalık en yüksek
SGD 0,26
52 haftalık en düşük
SGD 0,10
HBK
-SGD 0,04
Tedavüldeki hisse senedi sayısı
267,53 Mn
Çalışan sayısı
111
Haberler
Web kaynaklarından ve haber iş ortaklarından
Simply Wall Street
·
26 dakika önce
What AAON Bears Saw Before The Fall
Trefis
·
27 dakika önce
1 S&P 500 Stock Hit A 52-Week Low On Friday
MarketBeat
·
30 dakika önce
iHeartMedia (NASDAQ:IHRT) Stock Price Down 7.3% - Should You Sell?
MarketWatch
·
8 saat önce
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profil
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Cordlife Group Ltd hakkında
CEOYiu Pang Fai
Çalışan Sayısı111
Kuruluş Tarihi2 May 2001
Genel Merkez-
SektörHealth care provider
Web Sitesicordlife.com